Dianthus Therapeutics Inc. (DNTH)
NASDAQ · Healthcare
Dianthus Therapeutics Inc. Shareholder Equity 2016–2025
Dianthus Therapeutics Inc. annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Dianthus Therapeutics Inc. shareholder equity as of December 31, 2025: 493.4M, a 39.98% increase year-over-year.
- Dianthus Therapeutics Inc. shareholder equity for 2025 were 493.4M, a 39.98% increase from 2024.
- Dianthus Therapeutics Inc. shareholder equity for 2024 were 352.5M, a 108.73% increase from 2023.
- Dianthus Therapeutics Inc. shareholder equity for 2023 were 168.9M, a 19.60% increase from 2019.
- Dianthus Therapeutics Inc. shareholder equity for 2019 were 141.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Dianthus Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $493 |
| 2024 | $352 |
| 2023 | $169 |
| 2019 | $141 |
| 2018 | $146 |
| 2017 | $-42 |
Dianthus Therapeutics Inc. Shareholder Equity — FAQ
Dianthus Therapeutics Inc. (DNTH) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DNTH's shareholder equity history?
The chart and table above show Dianthus Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.